The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-3-((4-(4-Cyano-2-methylphenyl)piperazin-1-yl)sulfonyl)-N-hydroxythiazolidine-4-carboxamide ID: ALA3770935
PubChem CID: 117094707
Max Phase: Preclinical
Molecular Formula: C16H21N5O4S2
Molecular Weight: 411.51
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(C#N)ccc1N1CCN(S(=O)(=O)N2CSC[C@@H]2C(=O)NO)CC1
Standard InChI: InChI=1S/C16H21N5O4S2/c1-12-8-13(9-17)2-3-14(12)19-4-6-20(7-5-19)27(24,25)21-11-26-10-15(21)16(22)18-23/h2-3,8,15,23H,4-7,10-11H2,1H3,(H,18,22)/t15-/m1/s1
Standard InChI Key: UGVOWFLXYXPRQV-OAHLLOKOSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -3.0008 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.2993 -3.7521 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0394 -3.6005 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0391 -2.4007 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 3.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3002 3.7488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3026 5.2488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0048 6.0009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2954 5.2529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2978 3.7529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0072 7.5017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0091 8.7017 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3380 3.1546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4361 -5.2330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9031 -5.5458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6540 -4.2472 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.6510 -3.1318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3124 -6.2238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5499 -7.4000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.1104 -5.7460 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.0105 -6.5396 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 1 1 0
6 7 1 0
7 8 1 0
7 9 2 0
7 10 2 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
3 11 1 0
17 18 3 0
14 17 1 0
16 19 1 0
8 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 8 1 0
20 24 1 1
24 25 2 0
24 26 1 0
26 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 411.51Molecular Weight (Monoisotopic): 411.1035AlogP: 0.11#Rotatable Bonds: 4Polar Surface Area: 116.98Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.70CX Basic pKa: 0.00CX LogP: 0.16CX LogD: 0.14Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.53Np Likeness Score: -1.79
References 1. Camodeca C, Nuti E, Tepshi L, Boero S, Tuccinardi T, Stura EA, Poggi A, Zocchi MR, Rossello A.. (2016) Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models., 111 [PMID:26871660 ] [10.1016/j.ejmech.2016.01.053 ]